Temas Resources Corp. (TMASF)
OTCMKTS · Delayed Price · Currency is USD
0.1572
+0.0033 (2.13%)
Aug 6, 2025, 12:15 PM EDT
Revance Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.